Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Belgium-based AARDEX® Group, the leader in measuring and managing medication adherence in clinical trials today announced a strategic partnership with etectRx, Inc. This new collaboration combines etectRx’s ingestible event marker, the ID-Cap™ System...
read more
Wednesday, April 27, 2022
Biopharmaceutical contract development and manufacturing organization (CDMO) Scorpion Biological Services (Scorpion) today announced a planned development partnership with a private developer, the State of Kansas, and local and university affiliates,...
read more
Inotiv, Inc. announced the acquisition of Histion, LLC, effective April 25, 2022. The acquisition is a strategic element of the company’s expansion of its specialized pathology services.
read more
ProteoNic and NecstGen announced a partnership for the development of improved viral vector manufacturing for gene therapy applications.
read more
Lonza and Integral Molecular announced a strategy to offer complementary expertise to their respective customers to better assess the risks of off-target binding of biologic drug candidates.
read more
Catalent announced a multi-year $350 million investment at its facility in Bloomington, Indiana, to expand biologics drug substance and drug product manufacturing capabilities. The project will serve the industry’s robust biologics pipeline across ...
read more
Heat Biologics, Inc. is changing the name of the company to NightHawk Biosciences, Inc., effective May 3, 2022, to better reflect the Company’s evolution, including expansion of its therapeutic pipeline, the vertical integration of capabilities from ...
read more
BIOVECTRA has broken ground on a cutting-edge facility that will manufacture mRNA vaccines and therapeutics starting in 2023.
read more
Wednesday, April 13, 2022
Cambrex announced the completion of a $50 million expansion of its large-scale active pharmaceutical ingredient (API) manufacturing capabilities at its Charles City, Iowa facility.
read more
Wednesday, April 13, 2022
Halozyme Therapeutics, Inc. and Antares Pharma, Inc. have entered into a definitive agreement pursuant to which Halozyme will acquire Antares for $5.60 per share in cash. The transaction, which values Antares at approximately $960 million, was ...
read more
Wednesday, April 13, 2022
Biofrontera Inc. announced that the U.S. Food and Drug Administration (FDA) has approved Biofrontera Pharma’s cGMP laboratory in Leverkusen, Germany, as a contract laboratory for batch control and stability testing of Ameluz® (aminolevulinic acid ...
read more
Wednesday, April 13, 2022
ApiJect Systems, Corp. announced the launch of the ApiJect Technology Development Center in greater Orlando, FL.
read more
ReiThera Srl, a biotech company dedicated to the technology development, GMP manufacturing and clinical translation of genetic vaccines and medicinal products for advanced therapies, and Exothera, a full-service Contract Development and Manufacturing...
read more
As a consequence of the initial vaccine shortages in the coronavirus pandemic, the German government is securing vaccine production and supplies for the years ahead.
read more
Venomtech is collaborating with Charles River Laboratories, International Inc. to help drug developers explore venom-derived compounds for a wide range of therapeutic targets.
read more